 |
|
|
| |
Simeprevir and Sofosbuvir Regimens for Hepatitis C: Decompensation and Serious Adverse Events
|
| |
| |
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Poster pdf attached for improved view of large Table
Download the PDF her
P. Perumalswami1, K. Bichoupan1, N. Patel1, L. Ku1, R. Yalamanchili1, T. Schiano1, M. Woodward2, D. Dieterich1, A. Branch1 1. Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, United States. 2.The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
|
| |
|
|
|
|
|
